Table 3.
Covariate | OS | DFS | PFS | ||||||
---|---|---|---|---|---|---|---|---|---|
p value | HR | CI | p value | HR | CI | p value | HR | CI | |
All (HPVA and NHPVA) | |||||||||
HPV status | 0.060 | 0.14 | 0.03–0.95 | 0.064 | 0.14 | 0.02–1.02 | 0.81 | 1.3 | 0.14–11 |
Age | 0.95 | 1 | 0.96–1.05 | 0.77 | 1.01 | 0.96–1.05 | 0.97 | 1 | 0.96–1.04 |
Stage (I/II vs III/IV) | 0.056 | 7.73 | 1.32–33.8 | 0.044 | 8.43 | 1.47–37.3 | 0.65 | 1.45 | 0.3–7.09 |
Grade (1 vs 2 vs 3) | 0.34 | 3.42, 3.51 | 0.21–520, 0.27–494 | 0.39 | 2.55, 2.98 | 0.16–393, 0.23–416 | 0.067 | 0.37 | 0.13–1.08 |
Size | 0.10 | 1.03 | 0.99–1.07 | 0.067 | 1.04 | 1–1.08 | 0.48 | 0.99 | 0.96–1.02 |
Silva pattern (A/ B vs C) | 0.09 | 3.5 | 0.4–458 | 0.18 | 2.29 | 0.24–304 | - | - | - |
HPVA only | |||||||||
Age | 0.83 | 1.01 | 0.96–1.05 | 0.63 | 1.02 | 0.96–1.06 | 0.96 | 1 | 0.96–1.04 |
Stage (I/II vs III/IV) | 0.072 | 6.98 | 1.17–30 | 0.056 | 7.48 | 1.31–32 | 0.73 | 1.32 | 0.27–6.4 |
Grade (1 vs 2 vs 3) | 0.95 | 0.33, 0.3 | 0–64, 0–65 | 0.99 | 0.32, 0.33 | 0–63, 0–74 | 0.072 | 0.38 | 0.13–1.1 |
Size | 0.19 | 1.03 | 0.99–1.07 | 0.10 | 1.03 | 0.99–1.08 | 0.44 | 0.99 | 0.96–1.02 |
Silva pattern (A/B vs C) | 0.086 | 4.14 | - | 0.18 | 2.58 | - | - | - | - |
NHPVA only | |||||||||
Age | 0.032 | 1.06 | 1–1.1 | 0.052 | 1.09 | 1–1.18 | 0.51 | 1.02 | 0.96–1.1 |
Stage (I/II vs III/IV) | 0.022 | 8×109 | - | 0.0044 | 5×1022 | - | 1 | 9×108 | - |
Grade (1 vs 2 vs 3) | 0.54 | 0.35, 1.17 | 0.02–5.5, 0.18–7.4 | 0.098 | 0, 0.74 | 0.09–6.06 | 0.44 | 0.4 | 0.04–4.03 |
Size | 0.0022 | 1.1 | 1.01–1.19 | 0.0035 | 1.1 | 1.01–1.2 | 0.27 | 1.04 | 0.97–1.1 |
Silva pattern (A/B vs C) | - | - | - | - | - | - | - | - | - |